Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 8451–8500 of 34746
the Company’s Board of Directors appointed Judy Su as a Class I Director, Jatinder Dhaliwal and Katharyn Field as Class II directors, and Gary Herman as a Class III director of the Company.
each of Barbara Ruskin, Jerrold Sendrow, Jeffrey Gudin, Thani Jambulingam and Michael F. Dubin resigned as directors of the Company
the Company’s Board of Directors appointed Judy Su as a Class I Director, Jatinder Dhaliwal and Katharyn Field as Class II directors, and Gary Herman as a Class III director of the Company.
the Company’s Board of Directors appointed Judy Su as a Class I Director, Jatinder Dhaliwal and Katharyn Field as Class II directors, and Gary Herman as a Class III director of the Company.
each of Barbara Ruskin, Jerrold Sendrow, Jeffrey Gudin, Thani Jambulingam and Michael F. Dubin resigned as directors of the Company
each of Barbara Ruskin, Jerrold Sendrow, Jeffrey Gudin, Thani Jambulingam and Michael F. Dubin resigned as directors of the Company
the Company’s Board of Directors appointed Judy Su as a Class I Director, Jatinder Dhaliwal and Katharyn Field as Class II directors, and Gary Herman as a Class III director of the Company.
each of Barbara Ruskin, Jerrold Sendrow, Jeffrey Gudin, Thani Jambulingam and Michael F. Dubin resigned as directors of the Company
Effective on July 1, 2024, in connection with the effectiveness of the Registration Statement, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie became directors of the Company.
Effective on July 1, 2024, in connection with the effectiveness of the Registration Statement, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie became directors of the Company.
Effective on July 1, 2024, in connection with the effectiveness of the Registration Statement, Dr. M. Anthony Wong, Ms. Lauren Simmons, and Mr. Kevin McKenzie became directors of the Company.
On July 1, 2024, Genasys Inc. (the “Company”) received notice from Caltha Seymour of her resignation from the Board of Directors of the Company effective immediately due to increasing demands of her employment.
The Board of Directors (the "Board") of Voya Financial, Inc. (the "Company") appointed William J. Mullaney as a director of the Company, effective as of July 5, 2024.
The Board also approved the appointment of Mr. Shannon as a Class III director, effective as of the Transition Date.
On July 1, 2024, the Board of Directors (the “Board”) of Allied Gaming & Entertainment Inc. (the “Company”) appointed Mr. Mao Sun to serve as a director on the Board, effective immediately.
In addition, on July 1, 2024, Mr. Joseph Lahti resigned as a member of Board, effective immediately.
As described under Item 5.07 below, at the 2024 Annual Meeting, Nancy Howell Agee was elected to the Board, effective as of July 5, 2024.
As previously disclosed in the Proxy Statement, Dean Mitchell did not stand for re-election at 2024 Annual Meeting. Accordingly, Mr. Mitchell’s term on the Board ended effective as of July 5, 2024.
On June 28, 2024, Nassim Usman, Ph.D. informed the Company that he intended to resign from the Board, effective as of June 30, 2024.
On July 5, 2024, Edgardo Baracchini informed INmune Bio Inc. (the “Company”) of his resignation from the board of directors of the Company (the “Board”), effective immediately.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
each of the Company’s directors immediately prior to the Effective Time (Stanley P. Jaworski, Steve Smith, William Cooke, Richard Bravman, Michael N. Taglich and John Guttilla) resigned as directors of the Company.
At the Effective Time, Robert Newbold, Micheal Stewart and Steve Smith were appointed as directors of the Company.
At the Effective Time, Robert Newbold, Micheal Stewart and Steve Smith were appointed as directors of the Company.
At the Effective Time, Robert Newbold, Micheal Stewart and Steve Smith were appointed as directors of the Company.
On July 2, 2024, Christa Davies submitted her resignation from the Board of Directors (the “Board”) of Workday, Inc. (“Workday”), including from the Audit Committee of the Board (the “Audit Committee”), effective immediately.
Effective July 5, 2024, the Board, upon the recommendation of its Nominating and Governance Committee, appointed Dr. Yujie Wang (“Dr. Wang”) as a member of the Board.
On July 1, 2024, Prudence Kuai informed the Board of Directors (the “Board”) of HF Foods Group Inc. (the “Company”) of her intention to resign from the Board and all committees thereof, effective July 5, 2024.
On June 28, 2024, the Board of Directors (the “Board”) of Unicoin Inc. (the “Company”) resolved that Pilar Manch ó n’s initial term as a director on the Board had expired and acknowledged that as of June 28, 2024, Ms. Manch ó n shall no longer serve on the Board.
On June 28, 2024, the Board re-elected Silvina Moschini as a voting member of the Board, effective as of June 28, 2024.
Effective June 28, 2024, the Board of Directors (the “Board”) of Vintage Wine Estates, Inc. (the “Company”) appointed Ivona Smith as an independent director to the Board
On June 27, 2024 Mr. Turk Stovall and Mr. Bob Weerts were appointed to the Board of Directors of the Company by the Board.
On June 27, 2024 Mr. Turk Stovall and Mr. Bob Weerts were appointed to the Board of Directors of the Company by the Board.
appointed John P. Sheehan, President of the Company, as a Class I Director of the Board, effective July 3, 2024
on July 2, 2024, Mr. Bradley C. Barron was appointed to the board of directors (the “Board”) of Sunoco GP by the sole member of Sunoco GP pursuant to the provisions of the Amended and Restated Limited Liability Company Agreement of Sunoco GP dated September 25, 2012, as amended.
On June 28, 2024, Ashley M. Keating, a member of the Board of Directors (the “Board”) of Medpace Holdings, Inc. (the “Company”) notified the Company of her resignation, effective as of June 30, 2024.
The Board of the Company following a recommendation from the independent directors of the Board, unanimously approved that Dr. Dani S. Zander be elected to fill the Class III director vacancy on the Board of the Company, effective July 1, 2024
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
David N. Capobianco was appointed as chairman of the Board, and Jason Long, Matthew K. Morrow, Michael S. Sulton, Frank Bayouth, Kara Goodloe Harling, Ben Moore, Charles Watson, Ty Daul and Valerie P. Chase were appointed as members of the board.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.